1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARγ2)
- 31 March 2004
- journal article
- Published by Elsevier BV in Experimental Gerontology
- Vol. 39 (3), 333-338
- https://doi.org/10.1016/j.exger.2003.11.008
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Will reducing adopogenesis in bone increase bone mass?: PPARgamma2 as a key target in the treatment of age-related bone lossDrug News & Perspectives, 2003
- Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivationBiochemical and Biophysical Research Communications, 2002
- Changes in Bone Structure and Mass With Advancing Age in the Male C57BL/6J MouseJournal of Bone and Mineral Research, 2002
- Age-Related Bone Loss: Old Bone, New FactsGerontology, 2002
- Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Δ12,14-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2Prostaglandins, Leukotrienes & Essential Fatty Acids, 2001
- Anabolic Agents to Treat Osteoporosis in Older People: Is There Still Place for Fluoride?Journal of the American Geriatrics Society, 2001
- Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosisBiogerontology, 2001
- Marrow stromal stem cellsJCI Insight, 2000
- Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARγ ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cellsLife Sciences, 1998
- CAAT/Enhancer Binding Proteins Directly Modulate Transcription from the Peroxisome Proliferator- Activated Receptor γ2 PromoterBiochemical and Biophysical Research Communications, 1997